1 Followers on Owler

Cheplapharm

Read more
CEO Avatar

CEO

Sebastian F Braun

CEO Approval Rating

- -/100

Founded:

1998

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees
Sector

Update Industry

Cheplapharm Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Zineryt®

Aug 2020

Source »
undisclosed
-

-

Pimafucin®

Aug 2020

Source »
undisclosed
-

-

Locoid®

Aug 2020

Source »
undisclosed
-

-

One-Alpha®

Aug 2020

Source »
undisclosed
-

These are all the companies that Cheplapharm has acquired. Cheplapharm has acquired 4 companies and its latest acquisition was Zineryt® in Aug 2020.

Cheplapharm Funding History

No recent funding data found related to Cheplapharm

Cheplapharm Investments

No recent investments found related to Cheplapharm

Cheplapharm News

March 7, 2021Emirates Business

German drugmaker weighs $10b IPO

Bloomberg Cheplapharm Arzneimittel GmbH, the German drugmaker, is weighing plans for an initial publi... See more »
January 7, 2021Post Online Media

Takeda completes sale of select non-core assets to Cheplapharm

Takeda Pharmaceutical Company Limited announced the completion of its previously-announced sale of a ... See more »
January 4, 2021CompanyNews HQ

Atacand divestment to Cheplapharm in more than 70 countries completed

04 January 2021 07:00 GMT AstraZeneca has completed the divestment of commercial rights to Atacand (... See more »
November 2, 2020Pharmaceutical Business Review

Cheplapharm to buy AstraZeneca's heart failure and hypertension drugs for $400m

Under the deal, Cheplapharm will purchase Atacand (candesartan cilexetil) and Atacand Plus (a fixed-d... See more »
October 30, 2020Endpoints News

AstraZeneca sells off heart failure and hypertension drugs to Cheplapharm for $400M

Out with the old and in with the new: AstraZeneca is selling off two heart failure and hypertension d... See more »
October 30, 2020City A.M.

AstraZeneca strikes 307m deal for heart and blood pressure medicines

UK pharmaceutical giant AstraZeneca (AZN) said today it will sell the commercial rights for two of it... See more »
September 9, 2020Pharmaceutical Business Review

Takeda divests select non-core assets in Europe to Cheplapharm for approximately $562m

Cheplapharm is a specialty pharmaceutical company headquartered in Germany with a 25-year history of ... See more »

Cheplapharm Press Releases

Social Media

Cheplapharm Headquarters

Ziegelhof 24

Greifswald, Mecklenburg-Vorpommern17489

49-3834-3914-0

Driving Directions »

Trending Companies

Cheplapharm Summary

ABOUT

Overview

Cheplapharm is a pharmaceutical company that researches, develops, and commercializes drugs for the healthcare industry. Cheplapharm was founded in 1998. Cheplapharm's headquarters is located in Greifswald, Mecklenburg-Vorpommern, DE 17489. ...

Frequently Asked Questions about Cheplapharm

  1. When was Cheplapharm founded?

    Cheplapharm was founded in 1998
  2. Who is Cheplapharm's CEO?

    Cheplapharm's CEO is Sebastian F Braun
  3. How much revenue does Cheplapharm generate?

    Cheplapharm generates $ < 1M in revenue
  1. How much funding does Cheplapharm have?

    Cheplapharm has historically raised $0 in funding
  2. Where is Cheplapharm's headquarters?

    Cheplapharm's headquarters is in Greifswald Mecklenburg-Vorpommern, DE
  3. How many employees does Cheplapharm have?

    Cheplapharm has 0 employees